Weekly Discussion Topic

The Biopharma Communicator’s Problem Statement

At a holiday networking event last week, someone doggedly kept asking me what problem I’m solving with our community.

I’ve always seen an OPPORTUNITY with T2B, but this line of questioning made me reconsider whether we are in fact a solution to a problem.

We all know that what we do as communicators in THIS industry is so unique and complicated and highly specialized.

We also know in our heart of hearts that we can have a huge impact on our individual clients and companies.

But have you thought about how much we as an industry are holding ourselves back with the current conservative, siloed structure?

To put a finer point on it, I suppose the problem statement here is a future WITHOUT any changes to the status quo across our profession.

Ask yourself this: What’s the point of all of our colleagues’ tireless hours in the lab, painstaking study designs, negotiating with regulators – all of it – if the people who need to know about this work don’t know about it or understand it?

Or worse, what if these medical advances of the future are acknowledged but then rejected?

Honestly, in my opinion, none of it matters if we’re not reaching the people who are meant to receive these updates and making a lasting impression in their hearts and minds.

With an uncertain political environment, mis-, dis-, and mal-information lurking in every corner, the beginnings of unprecedented technological shifts with AI, and a huge trust problem with our industry, we can’t afford NOT to challenge the status quo.

T2B’s mission from day 1 has been to create community by cultivating connections and conversations.

We’re constantly listening to all kinds of biopharma communicators and evolving HOW we create those opportunities, but with over 750 members, the need is apparent and the movement is real.

So, I challenge you to think bigger than maybe you have in the past.

What can YOU do to change the course of storytelling in human health, and how can we help you do that?